# DiaCon Dual-Hormone Closed-Loop Glucose Control

> **NCT02379299** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Hvidovre University Hospital**

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** DiaCon dual-hormone closed-loop glucose control algorithm
- **DEVICE:** DiaCon single-hormone closed-loop glucose control algorithm

## Key facts

- **NCT ID:** NCT02379299
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2017-07-22
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02379299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02379299, "DiaCon Dual-Hormone Closed-Loop Glucose Control". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02379299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*